perimenopause and semaglutide One of the biggest misconceptions I see in women navigating is that GLP-1 medications are simply “weight loss drugs.” That couldn't be further from the truth, it's time more women GLP-1 for Perimenopause Weight Loss:

Severe abdominal pain, especially upper abdominal pain radiating to the back (possible pancreatitis)

The maximum dose of semaglutide approved for weight management in the U.S

STEP-2 (N=1,210 adults with type 2 diabetes) confirmed that even the 1.0 mg dose of semaglutide produces clinically significant metabolic changes within 8-12 weeks, which is well within the timeframe that ovulatory function may normalize in previously anovulatory women

instead, CVS prefers generic older drugs (even recommending phone apps or Medicare-funded diet programs) as first steps ( [44] )

At present, the scientific evidence does not provide a simple answer